![Conor Kilroy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Conor Kilroy
Keine laufenden Positionen mehr
Vermögen: 2 Mio $ am 31.07.2026
Profil
Conor Kilroy worked as an Associate at Goodwin Procter LLP from 2007 to 2011.
Served as Counsel at Boston Scientific Corp.
from 2012 to 2013.
Held the position of Secretary, Senior Vice President & General Counsel at Ironwood Pharmaceuticals, Inc. from 2020 to 2021.
Worked as Secretary & General Counsel at Neurogastrx, Inc. from 2021 to 2023.
Served as Secretary & Chief Legal Officer at Aura Biosciences, Inc. from 2025 to 2026.
Completed undergraduate studies at Brandeis University and graduate studies at Boston College Law School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,22 % | 01.07.2026 | 232.693 ( 0,22 % ) | 2 Mio $ | 31.07.2026 |
Ehemalige bekannte Positionen von Conor Kilroy
| Unternehmen | Position | Ende |
|---|---|---|
| AURA BIOSCIENCES, INC. | General Counsel | 11.08.2026 |
Neurogastrx, Inc.
 Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | General Counsel | 01.05.2023 |
| IRONWOOD PHARMACEUTICALS, INC. | General Counsel | 01.02.2021 |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01.01.2013 |
Goodwin Procter LLP
 Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Corporate Officer/Principal | 01.01.2011 |
Ausbildung von Conor Kilroy
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
60
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Goodwin Procter LLP
Goodwin Procter LLP Investment ManagersFinance Functions as an alternative investment manager | Finance |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College Law School
 Boston College Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Health Technology |
